Cargando…

Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden

BACKGROUND: The prevalence of multimorbidity (the presence of two or more long-term conditions) is rising internationally. Multimorbidity affects patients by increasing their burden of symptoms, but is also likely to increase the self-care demands, or treatment burden, that they experience. Treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallacher, Katie I, Batty, G David, McLean, Gary, Mercer, Stewart W, Guthrie, Bruce, May, Carl R, Langhorne, Peter, Mair, Frances S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220053/ https://www.ncbi.nlm.nih.gov/pubmed/25280748 http://dx.doi.org/10.1186/s12916-014-0151-0

Ejemplares similares

How Does Sex Influence Multimorbidity? Secondary Analysis of a Large Nationally Representative Dataset
por: Agur, Karolina, et al.
Publicado: (2016)

Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis
por: Simpson, Robert J, et al.
Publicado: (2014)

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
por: Hanlon, Peter, et al.
Publicado: (2018)

A conceptual model of treatment burden and patient capacity in stroke
por: Gallacher, Katie I., et al.
Publicado: (2018)

The ‘everyday work’ of living with multimorbidity in socioeconomically deprived areas of Scotland
por: O’Brien, Rosaleen, et al.
Publicado: (2014)

Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database
por: McLean, Gary, et al.
Publicado: (2017)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study
por: Smith, Daniel J, et al.
Publicado: (2013)

Uncovering Treatment Burden as a Key Concept for Stroke Care: A Systematic Review of Qualitative Research
por: Gallacher, Katie, et al.
Publicado: (2013)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2019)

The influence of socioeconomic deprivation on multimorbidity at different ages: a cross-sectional study
por: McLean, Gary, et al.
Publicado: (2014)

Risk Factors and Mortality Associated with Multimorbidity in People with Stroke or Transient Ischaemic Attack: A Study of 8,751 UK Biobank Participants
por: Gallacher, Katie I., et al.
Publicado: (2018)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2018)

Challenges and Implications of Routine Depression Screening for Depression in Chronic Disease and Multimorbidity: A Cross Sectional Study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2013)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Practice postcode versus patient population: a comparison of data sources in England and Scotland
por: McLean, Gary, et al.
Publicado: (2008)

Understanding multimorbidity trajectories in Scotland using sequence analysis
por: Cezard, G., et al.
Publicado: (2022)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
por: von Buedingen, Fiona, et al.
Publicado: (2018)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
por: van den Akker, Marjan, et al.
Publicado: (2019)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Multimorbidity and comorbidity patterns in the English National Health Service
por: MacRae, Clare, et al.
Publicado: (2022)

Chronic migraine, comorbidity, and socioeconomic deprivation: cross-sectional analysis of a large nationally representative primary care database
por: McLean, Gary, et al.
Publicado: (2017)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Multimorbidity and the COVID-19 pandemic – An urgent call to action
por: Mair, Frances S, et al.
Publicado: (2020)

A qualitative evaluation of general practitioners’ views on protocol-driven eReferral in Scotland
por: Bouamrane, Matt-Mouley, et al.
Publicado: (2014)

What helps and hinders the provision of healthcare that minimises treatment burden and maximises patient capacity? A qualitative study of stroke health professional perspectives
por: Kyle, John, et al.
Publicado: (2020)

Maternal multimorbidity and preterm birth in Scotland: an observational record-linkage study
por: Azcoaga-Lorenzo, Amaya, et al.
Publicado: (2023)

Variation in multimorbidity prevalence by number of long-term conditions counted: primary care population cross-sectional study.
por: MacRae, Clare, et al.
Publicado: (2022)

Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator
por: Assari, Shervin, et al.
Publicado: (2019)

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rgrv8o5l5eirem07flnla6mnmf